Xenoscience Inc. is a clinical research site located in Phoenix, Arizona, United States 85013.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Xenoscience Inc. has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Alzheimer's Disease, Preclinical Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease.
Sponsors: Biogen, Janssen Pharmaceutica N.V., Belgium, Chelsea Therapeutics.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Xenoscience Inc. has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Xenoscience Inc. has 8 clinical trials on record, with 2 currently active. Their work covers Alzheimer's Disease, Preclinical Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease.
Yes — Xenoscience Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.